Entera Bio Ltd.
ENTX
Revenue
57.00k
▲57.00k∞%
9 Months ChangeAssets
28.94M
▲18.68M▲182.00%
6 Months ChangeLiabilities
3.62M
▲27.00k▲0.7506%
6 Months ChangeFree Cash Flow
-1.86M
▼-242.00k▼-14.94%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-09
Form 10-Q
ID: 0001178913-24-002522
2024-08-09
Form 8-K
ID: 0001178913-24-002520
2024-08-02
Form 8-K
ID: 0001178913-24-002393
2024-05-10
Form 10-Q
ID: 0001178913-24-001683
2024-05-10
Form 8-K
ID: 0001178913-24-001681
2024-03-08
Form 8-K
ID: 0001178913-24-000879
2024-03-04
Form 8-K
ID: 0001178913-24-000794
2024-02-02
Form 8-K
ID: 0001178913-24-000353
2024-01-03
Form 8-K
ID: 0001178913-24-000035
2023-12-26
Form 8-K
ID: 0001178913-23-003962